Table 3 Gastric atrophy defined by other serology criteria in literature and its association with OSCC risk
Controls, N (%) | Cases, N (%) | Adjusted OR (95% CI) a | |
---|---|---|---|
PGI | |||
PGI ⩾30 | 500 (95.4) | 274 (93.5) | Referent |
PGI <30 | 24 (4.6) | 19 (6.5) | 1.52 (0.79–2.93) |
Stratifying by PGII level b | |||
PGI ⩾30 and PGII<11.8 | 226 (43.1) | 97 (33.1) | Referent |
PGI <30 and PGII <11.8 | 4 (0.8) | 3 (1.0) | 1.94 (0.91–4.13) |
PGI ⩾30 and PGII ⩾11.8 | 274 (52.3) | 176 (60.4) | Referent |
PGI <30 and PGII ⩾11.8 | 20 (3.8) | 16 (5.5) | 1.10 (0.23–5.17) |
PGI/PGII ratio b | |||
Ratio ⩾3 | 490 (93.5) | 265 (90.8) | Referent |
Ratio <3 | 34 (6.5) | 27 (9.2) | 1.50 (0.85–2.60) |
Stratifying by PGII level b | |||
Ratio ⩾3 and PGII <11.8 | 233 (44.5) | 100 (34.1) | Referent |
Ratio <3 and PGII <11.8 | 21 (4.0) | 14 (4.8) | 2.32 (1.00–5.39) |
Ratio ⩾3 and PGII ⩾11.8 | 257 (49.0) | 165 (56.7) | Referent |
Ratio<30 and PGII ⩾11.8 | 13 (2.5) | 13 (4.4) | 1.03 (0.49–2.20) |
PGI and PGI/PGII ratio b | |||
PGI ⩾70 or ratio ⩾3 | 497 (94.9) | 267 (91.5) | Referent |
PGI <70 and ratio <3 | 27 (5.1) | 25 (8.5) | 1.69 (0.93–3.10) |
Stratifying by PGII level b | |||
(PGI ⩾70 or ratio ⩾3) and PGII <11.8 | 233 (44.5) | 100 (34.19) | Referent |
(PGI <70 and ratio <3) and PGII <11.8 | 14 (2.6) | 12 (4.1) | 2.31 (0.99–5.38) |
(PGI ⩾70 or ratio ⩾3) and PGII ⩾11.8 | 264 (50.4) | 167 (57.4) | Referent |
(PGI <70 and ratio <3) and PGII ⩾11.8 | 13 (2.5) | 13 (4.4) | 1.24 (0.52–2.94) |